Category Archives: Top Market News

BMO Capital Maintains Their Hold Rating on Bristol Myers (BMY)

In a report released yesterday, Alex Arfaei from BMO Capital maintained a Hold rating on Bristol Myers (BMY – Research Report). The company’s shares closed yesterday at $53.27. According to TipRanks.com, Arfaei is a 5-star analyst with an average return

Cantor Fitzgerald Thinks Evofem Biosciences Inc’s Stock is Going to Recover

Cantor Fitzgerald analyst William Tanner reiterated a Buy rating on Evofem Biosciences Inc (EVFM – Research Report) yesterday and set a price target of $9. The company’s shares closed yesterday at $3.37, close to its 52-week low of $1.79. Tanner

Luxoft Holding (LXFT) Gets a Hold Rating from Credit Suisse

In a report released yesterday, Charles Brennan from Credit Suisse maintained a Hold rating on Luxoft Holding (LXFT – Research Report), with a price target of $38. The company’s shares closed yesterday at $33.30, close to its 52-week low of

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Receives a Buy from Oppenheimer

In a report released yesterday, Esther Rajavelu from Oppenheimer maintained a Buy rating on Biohaven Pharmaceutical Holding Co Ltd (BHVN – Research Report), with a price target of $63. The company’s shares closed yesterday at $34.25. Rajavelu said: “BHVN reported

KeyBanc Keeps a Buy Rating on BlackLine Inc (BL)

KeyBanc analyst Brent Bracelin maintained a Buy rating on BlackLine Inc (BL – Research Report) yesterday and set a price target of $56. The company’s shares closed yesterday at $39.04. Bracelin noted: “We lower our PT to $56 from $65

Oppenheimer Keeps a Buy Rating on Intec Pharma Ltd (NTEC)

Oppenheimer analyst Jay Olson maintained a Buy rating on Intec Pharma Ltd (NTEC – Research Report) yesterday and set a price target of $15. The company’s shares closed yesterday at $5.75. Olson commented: “NTEC reported a 3Q update with $9.5M